These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 14556197)
61. [Application of Helena SAS-3 full automatic hemoglobin agarose electrophoresis]. Mo JK; Zhang Z; Li YX; Lei D; Ma J Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1565-7. PubMed ID: 16361167 [TBL] [Abstract][Full Text] [Related]
62. An Evaluation for the Causes of Reduced Hb A Chan NCN; Wong THY; Cheng KCK; Chan NPH; Ng MHL Hemoglobin; 2021 Nov; 45(6):387-391. PubMed ID: 35168445 [TBL] [Abstract][Full Text] [Related]
63. Hb A2-Pasteur-Tunis [delta59(E3)Lys-->Asn, AAG-->AAC]: a new delta chain variant detected by DNA sequencing in a Tunisian carrier of the codon 39 (C-->T) beta0-Thalassemia mutation. Moumni I; Zorai A; Daoued BB; Mosbahi I; Omar S; Kaabachi N; Dellagi K; Abbes S Hemoglobin; 2007; 31(1):23-9. PubMed ID: 17365002 [TBL] [Abstract][Full Text] [Related]
64. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening. Li D; Liao C; Li J; Xie X; Huang Y; Zhong H Haematologica; 2006 May; 91(5):649-51. PubMed ID: 16627247 [TBL] [Abstract][Full Text] [Related]
66. Is Hb A2 elevated in adults with sickle-alpha-thalassemia (beta(S)/beta(S); -alpha/-alpha)? Ballas SK; Gay RN; Chehab FF Hemoglobin; 1997 Sep; 21(5):405-50. PubMed ID: 9322076 [TBL] [Abstract][Full Text] [Related]
67. Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants. Siriratmanawong N; Pinmuang-Ngam C; Fucharoen G; Fucharoen S Fetal Diagn Ther; 2007; 22(4):264-8. PubMed ID: 17369692 [TBL] [Abstract][Full Text] [Related]
68. [Analysis of clinical phenotypes of compound heterozygotes of Hb J-Bangkok and β-thalassemia]. Zhao Y; Shang X; Xiong F; Liu YH; Lou JW; Xu XM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):148-51. PubMed ID: 23568723 [TBL] [Abstract][Full Text] [Related]
69. A rare example that coinheritance of a severe form of beta-thalassemia and alpha-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes. Kanavakis E; Traeger-Synodinos J; Lafioniatis S; Lazaropoulou C; Liakopoulou T; Paleologos G; Metaxotou-Mavrommati A; Stamoulakatou A; Papassotiriou I Blood Cells Mol Dis; 2004; 32(2):319-24. PubMed ID: 15003825 [TBL] [Abstract][Full Text] [Related]
70. Beta-thalassemia in association with a new delta-chain hemoglobin variant [delta116(g18)Arg-->Leu]: implications for carrier screening and prenatal diagnosis. Waye JS; Patterson M; Walker L; Eng B; Nakamura LM; Lafferty JD; Yong SL; Wu JK; Chui DH Am J Hematol; 2003 Nov; 74(3):179-81. PubMed ID: 14587045 [TBL] [Abstract][Full Text] [Related]
71. A newly modified hemoglobin H inclusion test as a secondary screening for α(0)-thalassemia in Southeast Asian populations. Fucharoen G; Yooyen K; Chaibunruang A; Fucharoen S Acta Haematol; 2014; 132(1):10-4. PubMed ID: 24356175 [TBL] [Abstract][Full Text] [Related]
72. High frequency of deletional alpha-thalassemia in beta-thalassemia trait: implications for genetic counseling. Panigrahi I; Rafeeq PH; Choudhry VP; Saxena R Am J Hematol; 2004 Jul; 76(3):297-9. PubMed ID: 15224373 [TBL] [Abstract][Full Text] [Related]
73. Normal Hb A2 β-thalassemia trait: frameshift mutation (HBB: c.187_251dup) in cis with the Hb A2' δ-globin gene missense mutation (HBD: c.49G>C). Waye JS; Eng B; Hellens L; Hohenadel BA; Nakamura LM; Walker L Hemoglobin; 2013; 37(2):201-4. PubMed ID: 23398055 [TBL] [Abstract][Full Text] [Related]
74. Hb A2' (Hb B2) in the Omani population and diagnostic significance. Daar S; Al Zadjali S; Gravell D; Al Haddabi H; Al Riyami M; Al Belushi A; Berbar T; Krishnamoorthy R Hemoglobin; 2011; 35(2):117-24. PubMed ID: 21417568 [TBL] [Abstract][Full Text] [Related]
75. Hematological phenotype of the IVS-I-5 (G > C) beta-thalassemia mutation and assessment of Iran's national screening criteria. Eshghi P; Rashidi A; Zadeh-Vakili A; Miri-Moghadam E Hemoglobin; 2008; 32(5):440-5. PubMed ID: 18932068 [TBL] [Abstract][Full Text] [Related]
76. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia]. Li LY; Li Q; Song LL; Jin WJ; Ma ZH; Yu YH; Zhong M Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739 [TBL] [Abstract][Full Text] [Related]
77. Quantification of HbA(2) in patients with and without beta-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems. Higgins TN; Khajuria A; Mack M Am J Clin Pathol; 2009 Mar; 131(3):357-62. PubMed ID: 19233839 [TBL] [Abstract][Full Text] [Related]
78. Occurrence of common and rare δ-globin gene defects in two multiethnic populations: thirteen new mutations and the significance of δ-globin gene defects in β-thalassemia diagnostics. Phylipsen M; Gallivan MV; Arkesteijn SG; Harteveld CL; Giordano PC Int J Lab Hematol; 2011 Feb; 33(1):85-91. PubMed ID: 20678137 [TBL] [Abstract][Full Text] [Related]
79. Phenotypic expression of hemoglobins A₂, E and F in various hemoglobin E related disorders. Sae-ung N; Srivorakun H; Fucharoen G; Yamsri S; Sanchaisuriya K; Fucharoen S Blood Cells Mol Dis; 2012 Jan; 48(1):11-6. PubMed ID: 22014901 [TBL] [Abstract][Full Text] [Related]